文献速递肝病

自发性门体分流总横截面积独立预测肝硬化肝性脑病与死亡

Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis.
PubMed 文献 · J Hepatol · 2020-01-15

这项国际多中心回顾性研究评估了908例肝硬化合并自发性门体分流(SPSS)患者的CT影像,测量所有SPSS半径并计算总横截面积(TSA)。训练队列301例中,TSA>83 mm2者1年生存率更低(69% vs. 84%,p<0.001)、显性肝性脑病(oHE)发生率更高(47% vs. 33%,p<0.05),且TSA>83 mm2是死亡的独立预测因素(HR 1.66,95%CI 1.02-2.70,p<0.05);验证队列607例证实了上述结果。

要点

  • TSA>83 mm2的肝硬化患者1年生存率显著低于TSA≤83 mm2者。
  • TSA>83 mm2与显性肝性脑病发生风险增加独立相关。
  • TSA>83 mm2是肝硬化患者死亡的独立预测因素(HR 1.66)。

核心结论

  • TSA>83 mm2增加肝硬化患者发生oHE和死亡的风险。
  • TSA/SPSS可用于肝硬化患者的风险分层和临床决策。

研究设计与样本

  • 国际多中心回顾性研究,评估908例肝硬化合并SPSS患者的CT影像以测量TSA。
  • 训练队列301例(169例男性),验证队列607例。

主要发现

  • 30%的患者存在>1个SPSS。
  • L-TSA组MELD评分高于S-TSA组(11 vs. 14),oHE病史更常见(12% vs. 21%,p<0.05)。
  • 训练队列中L-TSA组随访期间oHE发作更多(33% vs. 47%,p<0.05),1年生存率更低(84% vs. 69%,p<0.001)。
  • 多因素分析显示L-TSA是死亡的独立预测因素(HR 1.66;95%CI 1.02-2.70,p<0.05)。
  • 验证队列中L-TSA组1年生存率更低(77% vs. 64%,p<0.001),oHE发生率更高(35% vs. 49%,p<0.001)。

关键数值与推荐

  • TSA截断值为83 mm2,用于区分小TSA(S-TSA)和大TSA(L-TSA)。

临床怎么用

  • 临床可利用TSA/SPSS对肝硬化患者进行风险分层和决策支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Spontaneous portosystemic shunts (SPSS) frequently develop in liver cirrhosis. Recent data suggested that the presence of a single large SPSS is associated with complications, especially overt hepatic encephalopathy (oHE). However, the presence of >1 SPSS is common. This study evaluates the impact of total cross-sectional SPSS area (TSA) on outcomes in patients with liver cirrhosis. METHODS: In this retrospective international multicentric study, CT scans of 908 cirrhotic patients with SPSS were evaluated for TSA. Clinical and laboratory data were recorded. Each detected SPSS radius was measured and TSA calculated. One-year survival was the primary endpoint and acute decompensation (oHE, variceal bleeding, ascites) was the secondary endpoint. RESULTS: A total of 301 patients (169 male) were included in the training cohort. Thirty percent of all patients presented with >1 SPSS. A TSA cut-off of 83 mm2 was used to classify patients with small or large TSA (S-/L-TSA). Patients with L-TSA presented with higher model for end-stage liver disease score (11 vs. 14) and more commonly had a history of oHE (12% vs. 21%, p <0.05). During follow-up, patients with L-TSA experienced more oHE episodes (33% vs. 47%, p <0.05) and had lower 1-year survival than those with S-TSA (84% vs. 69%, p <0.001). Multivariate analysis identified L-TSA (hazard ratio 1.66; 95% CI 1.02-2.70, p <0.05) as an independent predictor of mortality. An independent multicentric validation cohort of 607 patients confirmed that patients with L-TSA had lower 1-year survival (77% vs. 64%, p <0.001) and more oHE development (35% vs. 49%, p <0.001) than those with S-TSA. CONCLUSION: This study suggests that TSA >83 mm2 increases the risk for oHE and mortality in patients with cirrhosis. Our results support the clinical use of TSA/SPSS for risk stratification and decision-making in the management of patients with cirrhosis. LAY SUMMARY: The prevalence of spontaneous portosystemic shunts (SPSS) is higher in patients with more advanced chronic liver disease. The presence of more than 1 SPSS is common in advanced chronic liver disease and is associated with the development of hepatic encephalopathy. This study shows that total cross-sectional SPSS area (rather than diameter of the single largest SPSS) predicts survival in patients with advanced chronic liver disease. Our results support the clinical use of total cross-sectional SPSS area for risk stratification and decision-making in the management of SPSS.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Praktiknjo M, Simón-Talero M, Römer J, et al. Total area of spontaneous portosystemic shunts independently predicts hepatic encephalopathy and mortality in liver cirrhosis. J Hepatol. 2020. PMID: 31954206. doi:10.1016/j.jhep.2019.12.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。